Project Grant R21AG073869
Award Date
8/15/21
Completion Date
9/1/21
Dollars Obligated
$205K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Texas, USA
Similar Awards
This federal Project Grant award of $268,377 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports the development and validation of a novel medical device to accelerate the healing of stage 2 diabetic foot ulcers (DFUs) using high-frequency, low amplitude vibration (HFLAV) technology. The key objectives are to: (1) enhance and validate the driver device by...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is funding a $555,034 randomized controlled trial titled "Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-FOOT-NAV)." The study aims to assess the effectiveness of a navigator program in improving diabetic foot ulcer (DFU) healing rates and...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $312,492 to Anxomics LLC to develop a deep learning-based platform for the remote management and analysis of diabetic foot ulcers (DFUs). The goal is to create a mobile application that can accurately detect wound infection and ischemia using images captured by conventional smartphones,...
Vivonics Inc., a medical technology company based in Massachusetts, received a $331,455 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) to develop a near-infrared layered imaging system called NIR-LITH. This system aims to provide objective, three-dimensional hemodynamic mapping of diabetic foot ulcers and surrounding tissue with 1 mm depth resolution, improving clinicians' ability to assess wound healing potential and make more accurate...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Barron Associates, Inc. a $712,628 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The funding supports the development of the SoleSaver System, a sensor-enabled foot-worn garment that continuously monitors pressure, temperature, gait indices, and peripheral arterial disease status to enhance prevention and minimize recurrence of diabetic foot ulcers....
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $687,416 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Lynntech Inc., a small business technology development company in College Station, Texas. The grant supports the development of a cutaneous gel that can controllably deliver a therapeutic with an intriguing mechanism of action to effectively address impaired wound healing in diabetic foot...
The National Institute of General Medical Sciences (NIGMS), under CFDA Program 93.859 Biomedical Research and Research Training, awarded a $176,840 Project Grant to the Rochester Institute of Technology (RIT) to develop a predictive mathematical model for obesity-induced type 2 diabetes mellitus (T2DM) and chronic wound healing. The goal is to create a model that realistically represents the key physiological factors correlated with the high prevalence of T1/T2 diabetes and impaired wound...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) will fund the development of an advanced wound care product to treat diabetic foot ulcers. The $305,000 award to Therapeutic Bandage Products, Inc. will support the creation of a patented microneedle bandage that delivers a combination of therapeutic agents to disinfect wounds, prevent biofilm formation, and activate the immune system to promote...
The University of Miami School of Medicine is conducting a R21 research project titled "Developing Biomarkers of Healing and Non-Healing VLUs" under a $371,470 award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The project aims to identify protein biomarkers in wound fluid that can predict healing outcomes and monitor progression of venous leg ulcers (VLUs), a common chronic wound condition. The researchers will analyze discarded wound...
The National Institute on Aging (NIA) awarded a $295,923 Project Grant (CFDA 93.866 - Aging Research) to Larix Bioscience LLC to develop novel hormonal therapeutics and study their efficacy with adult stem cells for the treatment of chronic pressure ulcers. The project aims to generate stable, bioactive hormone fusion biologics and evaluate their ability to enhance tissue regeneration in pressure ulcer patients, both alone and in combination with adipose-derived or induced pluripotent stem...